ROCKET PHARMACEUTICALS INC (RCKT) Stock Balance Sheet
USA - NASDAQ:RCKT - US77313F1066 - Common Stock
3.26 USD
+0.07 (+2.19%)
3.2458 USD
-0.01 (-0.44%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 32.82M | 163.63M | 55.90M | 140.50M | 232.70M | |||
| Marketable Securities | 238.68M | 208.70M | 317.27M | 215.90M | 156.00M | |||
| Other Current Assets | 5.66M | 5.85M | 5.05M | 7.70M | 3.30M | |||
| Total Current Assets | 277.00M | 378.00M | 378.00M | 364.10M | 392.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 78.00M | 83.00M | 88.00M | 77.60M | 72.30M | |||
| Investments And Advances | N/A | 0.00 | 34.00M | 43.30M | N/A | |||
| Goodwill | 39.00M | 39.00M | 39.00M | 39.20M | 30.80M | |||
| Intangibles | 25.00M | 25.00M | 25.00M | 25.70M | N/A | |||
| Other Non-Current Assets | 520.00K | 530.00K | 530.00K | 1.90M | 1.80M | |||
| Total Non-Current Assets | 144.00M | 150.00M | 188.00M | 187.70M | 104.90M | |||
| TOTAL ASSETS | 421.00M | 528.00M | 566.00M | 551.80M | 497.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.88M | 1.86M | 1.79M | 1.70M | 1.70M | |||
| Accrued Expenses | 40.00M | 37.00M | 32.00M | 35.20M | 20.00M | |||
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Liabilities | 1.71M | 1.63M | 15.00M | 2.30M | 500.00K | |||
| Total Current Liabilities | 43.00M | 41.00M | 49.00M | 39.20M | 22.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 19.00M | 19.00M | 19.00M | 19.30M | 19.10M | |||
| Other Non-Current Liabilities | 3.99M | 4.40M | 5.91M | 3.70M | 1.00M | |||
| Total Non-Current Liabilities | 24.00M | 23.00M | 25.00M | 22.90M | 20.10M | |||
| TOTAL LIABILITIES | 67.00M | 64.00M | 74.00M | 62.10M | 42.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.35B | -1.22B | -959.00M | -713.80M | -491.90M | |||
| Additional Paid In Capital | 1.70B | 1.68B | 1.45B | 1.20B | 946.20M | |||
| Common Shares | 1.08M | 1.07M | 900.00K | 800.00K | 600.00K | |||
| Treasury Stock | N/A | N/A | 0.00 | 0.00 | N/A | |||
| Other Shareholders' Equity | -110.00K | 70.00K | 320.00K | -400.00K | -200.00K | |||
| Shares Outstanding | 108.00M | 106.00M | 90.00M | 79.10M | 64.50M | |||
| Tangible Book Value per Share | 2.69 | 3.76 | 4.77 | 5.37 | 6.57 | |||
| Total Shareholders' Equity | 354.00M | 463.00M | 493.00M | 489.70M | 454.70M | |||
| TOTAL LIABILITIES AND EQUITY | 421.00M | 528.00M | 566.00M | 551.80M | 497.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | |||
| Current Ratio | 6.44 | 9.22 | 7.71 | 9.29 | 17.66 | |||
| Return On Assets (ROA) | -61.05% | -49.05% | -43.46% | -40.21% | -34.02% | |||
| Return On Equity (ROE) | -72.60% | -55.94% | -49.90% | -45.31% | -37.18% | |||
All data in USD , ROIC based on taxRate of 0.21